SCHEMBL1762078

SCHEMBL1762078

Nn1ccc(Br)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3820811 0.67
SCHEMBL5646014 0.67
SCHEMBL18782955 0.67
SCHEMBL17224628 0.62 MAPT (0.32)
SCHEMBL13547964 0.62
SCHEMBL9390665 0.62
SCHEMBL22579526 0.62
SCHEMBL3721832 0.62
SCHEMBL3794461 0.62
SCHEMBL17397928 0.60 KMT2A (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115873000-A Isoquinolone and quinazolinone compounds, and composition and application thereof 中山医诺维申新药研发有限公司 2023-03-31 CN disclosed
US-8937064-B2 Pyrazolo[1,5-a]pyrimidines useful as JAK2 inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2015-01-20 US disclosed
US-20110118255-A1 PYRAZOLO[1,5-a]PYRIMIDINES USEFUL AS JAK2 INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-05-19 US disclosed
EP-2252618-A1 PYRAZOLO [1,5-a] PYRIMIDINES USEFUL AS JAK2 INHIBITORS Vertex Pharmaceuticals Incorporated (US) 2010-11-24 EP disclosed
WO-2009085913-A1 PYRAZOLO [1,5-a] PYRIMIDINES USEFUL AS JAK2 INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-07-09 WO disclosed